Impact of age and gender on the safety and efficacy of chemotherapy plus bevacizumab in metastatic colorectal cancer: a pooled analysis of TRIBE and TRIBE2 studies

Survival in Advanced Esophagogastric Adenocarcinoma Improves With Use of Multiple Lines of Therapy: Results From an Analysis of More Than 500 Patients

(2018) Michael Davidson et al.   Clinical Colorectal Cancer

LBA20TRIBE2: A phase III, randomized strategy study by GONO in the 1st- and 2nd-line treatment of unresectable metastatic colorectal cancer (mCRC) patients (pts)

(2018) C Cremolini et al.   ANNALS OF ONCOLOGY

Impact of Sex on Chemotherapy Toxicity and Efficacy Among Patients With Metastatic Colorectal Cancer: Pooled Analysis of 5 Randomized Trials

(2018) Omar Abdel-Rahman   Clinical Colorectal Cancer

Management of Cancer in the Older Age Person: An Approach to Complex Medical Decisions

(2017) María Vallet‐Regí et al.   ONCOLOGIST

Improving the Evidence Base for Treating Older Adults With Cancer: American Society of Clinical Oncology Statement

(2015) Arti Hurria et al.   JOURNAL OF CLINICAL ONCOLOGY

First-line chemotherapy for mCRC—a review and evidence-based algorithm

(2015) Chiara Cremolini et al.   Nature Reviews Clinical Oncology

Initial Therapy with FOLFOXIRI and Bevacizumab for Metastatic Colorectal Cancer

(2014) Fotios Loupakis et al.   NEW ENGLAND JOURNAL OF MEDICINE

The Influence of Sex on Efficacy, Adverse Events, Quality of Life, and Delivery of Treatment in National Cancer Institute of Canada Clinical Trials Group Non-small Cell Lung Cancer Chemotherapy Trials

(2010) Paul Wheatley-Price et al.   Journal of Thoracic Oncology

Sex Differences in Pharmacokinetics and Pharmacodynamics

(2009) Offie P. Soldin et al.   CLINICAL PHARMACOKINETICS